Page 28 - JCTR-11-2
P. 28

Journal of Clinical and
            Translational Research                                                        US-mediated drug delivery



               treatment. Drug Des Devel Ther. 2013;7:375-388.    opening induced by focused ultrasound is dictated
                                                                  by the acoustic pressure.  J  Cereb  Blood  Flow Metab.
               doi: 10.2147/DDDT.S31564
                                                                  2014;34(7):1197-1204.
            29.  Tung YS, Vlachos F, Choi JJ, Deffieux T, Selert K,      doi: 10.1038/jcbfm.2014.71
               Konofagou  EE.  In vivo transcranial cavitation threshold
               detection during ultrasound-induced blood-brain barrier   40.  Schutt EG, Klein DH, Mattrey RM, Riess JG. Injectable
               opening in mice. Phys Med Biol. 2010;55(20):6141-6155.  microbubbles as contrast agents for diagnostic ultrasound
                                                                  imaging: The key role of perfluorochemicals. Angew Chem
               doi: 10.1088/0031-9155/55/20/007
                                                                  Int Ed Engl. 2003;42(28):3218-3235.
            30.  Bettinger T, Tranquart F. Design of microbubbles for gene/     doi: 10.1002/anie.200200550
               drug delivery. Adv Exp Med Biol. 2016;880:191-204.
                                                               41.  Klibanov AL. Microbubble contrast agents: Targeted
               doi: 10.1007/978-3-319-22536-4_11
                                                                  ultrasound imaging and ultrasound-assisted drug-delivery
            31.  Becher H,  Lofiego C,  Mitchell  A,  Timperley J.  Current   applications. Invest Radiol. 2006;41(3):354-362.
               indications for contrast echocardiography imaging.  Eur J      doi: 10.1097/01.rli.0000199292.88189.0f
               Echocardiogr. 2005;6(Suppl 2):S1-S5.
                                                               42.  Solans C, Izquierdo P, Nolla J, Azemar N, Garcia-Celma MJ.
               doi: 10.1016/s1525-2167(05)80722-x                 Nano-emulsions.  Curr Opin Colloid  Interface Sci.
            32.  Klibanov AL. Ultrasound molecular imaging with   2005;10(3):102-110.
               targeted microbubble contrast agents.  J  Nucl Cardiol.      doi: 10.1016/j.cocis.2005.06.004
               2007;14(6):876-884.
                                                               43.  Rapoport N, Nam KH, Gupta R, et al. Ultrasound-mediated
               doi: 10.1016/j.nuclcard.2007.09.008                tumor imaging and nanotherapy using drug loaded, block
            33.  McMahon D, O’Reilly MA, Hynynen K. Therapeutic agent   copolymer stabilized perfluorocarbon nanoemulsions.
               delivery across the blood-brain barrier using focused   J Control Release. 2011;153(1):4-15.
               ultrasound. Annu Rev Biomed Eng. 2021;23:89-113.     doi: 10.1016/j.jconrel.2011.01.022
               doi: 10.1146/annurev-bioeng-062117-121238       44.  Apfel RE. Activatable Infusable Dispersions Containing Drops
            34.  Yang FY, Fu WM, Yang RS, Liou HC, Kang KH, Lin WL.   of Superheated Liquid for Methods of Therapy and Diagnosis.
               Quantitative evaluation of focused ultrasound with a   Patent Number: 5,840,276; 1998
               contrast agent on blood-brain barrier disruption. Ultrasound   45.  Kripfgans OD, Fowlkes JB, Miller DL, Eldevik OP, Carson PL.
               Med Biol. 2007;33(9):1421-1427.                    Acoustic droplet vaporization for therapeutic and diagnostic
               doi: 10.1016/j.ultrasmedbio.2007.04.006            applications. Ultrasound Med Biol. 2000;26(7):1177-1189.
            35.  McDannold N, Vykhodtseva N, Hynynen K. Effects of      doi: 10.1016/s0301-5629(00)00262-3
               acoustic parameters and ultrasound contrast agent dose on   46.  Vlatakis S, Zhang W, Thomas S,  et al. Effect of phase-
               focused-ultrasound induced blood-brain barrier disruption.   change nanodroplets and ultrasound on blood-brain barrier
               Ultrasound Med Biol. 2008;34(6):930-937.           permeability in vitro. Pharmaceutics. 2023;16(1):51.
               doi: 10.1016/j.ultrasmedbio.2007.11.009            doi: 10.3390/pharmaceutics16010051
            36.  van Rooy I, Mastrobattista E, Storm G, Hennink WE,   47.  Wasielewska JM, White AR. Focused ultrasound-mediated
               Schiffelers RM. Comparison of five different targeting   drug  delivery in humans  -  a path towards translation in
               ligands to enhance accumulation of liposomes into the   neurodegenerative diseases. Pharm Res. 2022;39(3):427-439.
               brain. J Control Release. 2011;150(1):30-36.
                                                                  doi: 10.1007/s11095-022-03185-2
               doi: 10.1016/j.jconrel.2010.11.014
                                                               48.  Song R, Zhang C, Teng F,  et al. Cavitation-facilitated
            37.  Kucharz K, Kristensen K, Johnsen KB, et al. Post-capillary   transmembrane permeability enhancement induced by
               venules are the key locus for transcytosis-mediated brain   acoustically  vaporized  nanodroplets.  Ultrason Sonochem.
               delivery of therapeutic nanoparticles.  Nat Commun.   2021;79:105790.
               2021;12(1):4121.
                                                                  doi: 10.1016/j.ultsonch.2021.105790
               doi: 10.1038/s41467-021-24323-1
                                                               49.  Husseini GA, Diaz de la Rosa MA, Richardson ES,
            38.  Shpak O, Verweij M, de Jong N, Versluis M. Droplets,   Christensen DA, Pitt WG. The role of cavitation in
               Bubbles and ultrasound interactions.  Adv Exp Med Biol.   acoustically activated drug delivery.  J  Control Release.
               2016;880:157-174.                                  2005;107(2):253-261.
               doi: 10.1007/978-3-319-22536-4_9                   doi: 10.1016/j.jconrel.2005.06.015
            39.  Chen H, Konofagou EE. The size of blood-brain barrier   50.  Meijering BDM, Juffermans LJM, van Wamel A,  et  al.


            Volume 11 Issue 2 (2025)                        22                            doi: 10.36922/jctr.24.00061
   23   24   25   26   27   28   29   30   31   32   33